#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	4392	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2532	419.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1707	1707	C	535	C,A,G	497,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	4392	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2532	419.3	0	HET	.	.	.	C207T	.	207	207	C	730	730	C	429	C,T	298,91	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7390	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3979	456.9	0	.	n	.	0	T695C	SNP	695	695	T	1229	1229	C	595	C,A,T,G	547,5,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7390	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3979	456.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2172	2172	G	520	G,A,T	491,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7390	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3979	456.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2505	2505	C	514	C,G,A	479,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7390	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3979	456.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2579	2579	A	528	A,T	499,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7390	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3979	456.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3131	3131	C	456	C,T,G	437,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	448	folP	855	855	100.0	folP.l6.c4.ctg.1	2042	54.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1292	1294	AGC	66;70;70	A;G;C	62;65;65	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1010	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4077	60.9	1	SNP	p	S91F	1	.	.	271	273	TTC	955	957	TTC	73;73;73	T;T,G;C	66;68,1;71	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1010	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4077	60.9	1	SNP	p	D95G	1	.	.	283	285	GGC	967	969	GGC	79;79;79	G;G;C	77;76;74	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1010	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4077	60.9	1	SNP	p	G95N	0	.	.	283	285	GGC	967	969	GGC	79;79;79	G;G;C	77;76;74	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	414	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1845	55.4	1	SNP	p	G45D	0	.	.	133	135	GGC	725	727	GGC	101;101;101	G,C;G;C	89,1;90;90	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	262	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1524	42.2	0	.	n	.	0	A197.	DEL	197	197	A	879	879	A	82	A	78	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	768	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3488	54.0	1	SNP	p	D86N	0	.	.	256	258	GAC	862	864	GAC	44;44;45	G;A;C	39;38;41	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	768	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3488	54.0	1	SNP	p	R87I	0	.	.	259	261	CGT	865	867	CGT	46;46;51	C;G,T;T,C	44;39,1;47,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	768	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3488	54.0	1	SNP	p	R87W	0	.	.	259	261	CGT	865	867	CGT	46;46;51	C;G,T;T,C	44;39,1;47,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	768	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3488	54.0	1	SNP	p	S87R	1	.	.	259	261	CGT	865	867	CGT	46;46;51	C;G,T;T,C	44;39,1;47,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	768	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3488	54.0	1	SNP	p	S88P	0	.	.	262	264	TCC	868	870	TCC	51;51;52	T,G;C;C	45,1;49;51	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	742	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3196	57.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1869	1871	GGC	58;58;58	G;G;C	55;53;54	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1619	1621	GCC	114;115;115	G;C;C	106;109;110	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1622	1624	ATG	115;115;115	A,T;T;G	109,1;110;110	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1634	1636	ACC	114;114;114	A;C;C	105;109;109	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1634	1636	ACC	114;114;114	A;C;C	105;109;109	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2135	2137	ACC	109;109;108	A;C,A;C	98;95,1;100	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2189	2191	GCG	112;110;110	G;C,A;G,T	102;97,1;95,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2189	2191	GCG	112;110;110	G;C,A;G,T	102;97,1;95,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2312	2314	GGT	83;82;77	G,A;G,T,A;T,G	80,1;78,2,1;75,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2321	2323	AGC	62;61;61	A,G;G;C	52,1;54;49	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	922	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2616	85.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2339	2341	CCG	51;49;48	C;C;G,C	46;42;42,4	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1242	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3513	86.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1798	1800	CCG	111;111;110	C,G,A;C,T;G,C	87,2,1;104,1;85,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	490	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2223	54.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	745	745	C	40	C	32	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	604	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2279	65.6	1	SNP	p	G120K	1	.	.	358	360	AAG	1077	1079	AAG	102;101;99	A;A,T;G	99;97,1;96	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	604	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2279	65.6	1	SNP	p	A121N	1	.	.	361	363	AAC	1080	1082	AAC	99;99;97	A,G;A,G;C	95,1;95,1;92	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	604	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2279	65.6	1	SNP	p	N121D	0	.	.	361	363	AAC	1080	1082	AAC	99;99;97	A,G;A,G;C	95,1;95,1;92	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2212	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5338	102.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	324	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1472	54.5	1	SNP	p	V57M	1	.	.	169	171	ATG	794	796	ATG	105;105;106	A;T;G	99;102;103	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
